Inactive Instrument
Crescita Therapeutics Inc. Stock
Stocks
CTX
CA2258471028
Personal Products
OTC Markets Traded| Manager | Title | Age | Since |
|---|---|---|---|
Serge Verreault
CEO | Chief Executive Officer | - | 2018-04-01 |
Jose DaRocha
DFI | Director of Finance/CFO | - | 2017-11-06 |
Wade Hull
CTO | Chief Tech/Sci/R&D Officer | - | 2016-02-29 |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel Chicoine
CHM | Chairman | 72 | 2016-02-29 |
| Director/Board Member | - | 2016-02-29 | |
John London
BRD | Director/Board Member | - | 2016-02-29 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/3/26 | Marche | Chairman | -116,227 | 0.6244% | ||
| 6/3/26 | Marche | Director | -58,500 | 0.3143% | ||
| 6/3/26 | Marche | Director | -30,188 | 0.1622% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | +5.33% | - | - | 10.56M | ||
| -0.61% | +0.91% | +4.55% | +7.54% | 369B | ||
| -1.50% | +4.42% | +14.36% | +8.48% | 255B | ||
| -2.05% | -0.58% | -8.02% | +11.48% | 140B | ||
| -0.52% | -1.83% | +18.86% | +27.72% | 73.48B | ||
| +0.11% | +6.28% | +29.60% | - | 52.06B | ||
| -0.12% | -1.86% | -27.28% | -26.84% | 44.97B | ||
| +0.89% | +5.45% | +10.68% | -12.22% | 39.2B | ||
| -0.51% | +1.52% | +33.22% | +6.15% | 37.32B | ||
| -0.64% | +1.65% | -10.16% | -7.24% | 36.28B | ||
| Average | -0.49% | +1.71% | +7.31% | +1.88% | 116.41B | |
| Weighted average by Cap. | -0.90% | +1.71% | +6.88% | +6.90% |
Employees
65
Sector
Personal Products
















